Literature DB >> 7058766

The effects of calcium channel blocking agents on cardiovascular function.

R I Low, P Takeda, D T Mason, A N DeMaria.   

Abstract

The hemodynamic effects of calcium blocking agents are a composite of the various direct and indirect cardiac and peripheral vascular actions of these drugs on the individual determinants of left ventricular pump function. Calcium antagonists have been shown to have a direct negative inotropic effect, a direct negative chronotropic effect and a direct effect to produce relaxation of vascular smooth muscle and vasodilation. These agents may also elicit important indirect effects by an anti-ischemic action referable to both coronary arterial dilation and reduction in myocardial oxygen demand, as well as a baroreceptor-mediated reflex increase in beta adrenergic tone in response to vasodilation. The net result of these direct and indirect actions on cardiocirculatory dynamics is also dependent upon the individual calcium blocking agent administered, the dose and route of administration, and the underlying status of left ventricular function. Available data do not lead to a clear definition of the hemodynamic effects referable to calcium blocking agents that may be produced by the interaction of all variable factors. At present, however, it would appear that the direct negative inotropic and chronotropic actions of the calcium antagonists are offset by the reflex increase in beta adrenergic tone, in combination with the reduction in afterload produced by the peripheral vascular effects of these agents. Preliminary data suggest that certain calcium inhibiting agents may be useful in the vasodilator therapy of congestive heart failure. Nevertheless, the direct negative inotropic effects of these agents have resulted in clinically evident decompensation in cardiac performance in patients with advanced left ventricular dysfunction, and caution is warranted in the application of calcium blocking agents in this setting.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058766     DOI: 10.1016/s0002-9149(82)80010-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

2.  Acute treatment of hypertensive crisis with nifedipine.

Authors:  F T Huysmans; H E Sluiter; T A Thien; R A Koene
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 3.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 4.  Management of calcium channel antagonist overdose.

Authors:  Steven D Salhanick; Michael W Shannon
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  A comparison of the acute hemodynamic effects of nifedipine and nisoldipine in patients with ischemic reduced left ventricular function.

Authors:  C P Herbst; A C Otto; A van Aswegen; A Sweetlove; V Strugo
Journal:  Eur J Nucl Med       Date:  1987

6.  Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.

Authors:  J Su; N Renaud; A Carayon; B Crozatier; L Hittinger
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

Review 8.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

9.  Efficacy of the calcium antagonist isradipine in angina pectoris.

Authors:  J O Parker; M Enjalbert; V Bernstein
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

10.  [Seizure and non-cardiogenic pulmonary edema after intoxication].

Authors:  M Sawatzki; O Kummer; S Krähenbühl; M Siegemund
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.